Milrinone attenuates the negative inotropic effects of landiolol in halothane-anesthetized dogs

Canadian Journal of Anesthesia

Volumn 50, Issue 8, 2003, Pages 830-834

  Takahashi, Shinji ^a   Fujii, Yoshitaka ^a   Hoshi, Takuo ^a   Uemura, Aki ^a   Miyabe, Masayuki ^a   Toyooka, Hidenori ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOTONIC AGENT; DRUG DERIVATIVE; HALOTHANE; INHALATION ANESTHETIC AGENT; LANDIOLOL; MILRINONE; MORPHOLINE DERIVATIVE; SODIUM CHLORIDE; UREA;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MEGADOSE; FEMALE; HEART CONTRACTION; HEART OUTPUT; HEART RATE; HEMODYNAMIC PARAMETERS; INHALATION ANESTHESIA; INOTROPISM; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE;

EID: 0345688857     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03019382     Document Type: Article

References (17)

1. Gold MI, Sacks DJ, Grosnoff DB, Herrington C, Skillman CA. Use of esmolol during anesthesia to treat tachycardia and hypertension. Anesth Analg 1989; 68: 101-4.
2. Vucevic M, Purdy GM, Ellis FR. Esmolol hydrochloride for management of the cardiovascular stress responses to laryngoscopy and tracheal intubation. Br J Anaesth 1992; 68: 529-30.
3. Urban MK, Markowitz SM, Gordon MA, Urquhart BL, Kligfield P. Postoperative prophylactic administration of β-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 2000; 90: 1257-61.
4. Raby KE, Brull SJ, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 1999; 88: 477-82.
5. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999; 341: 1789-94.
6. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996; 335: 1713-20.
7. Iguchi S, Iwamura H, Nishizaki M, et al. Development of a highly cardioselective ultra short-acting β-blocker, ONO-1101. Chem Pharm Bull 1992; 40: 1462-9.
8. Takahashi S, Fujii Y, Inomata S, Miyabe M, Yoyooka H. Landiolol increases a dysrhythmogenic dose of epinephrine in dogs during halothane anesthesia. Can J Anesth 1999; 46: 599-604.
9. Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benton KT, Goto H. In rabbit, landiolol, a new ultra-short-acting β-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anesth 2001; 48: 985-9.
10. Heames RM, Gill RS, Ohri SK, Hett DA. Off-pump coronary artery surgery. Anaesthesia 2002; 57: 676-85.
11. Butterworth JF, Hines RL, Royster RL, James RL. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery. Anesth Analg 1995; 81: 783-92.
12. Skoyles JR, Sherry KM. Pharmacology, mechanisms of action and uses of selective phosphodiesterase inhibitors. Br J Anaesth 1992; 68: 293-302.
13. Takahashi S, Fujii Y, Hoshi T, Inomata S, Miyabe M, Toyooka H. Modifications of the hemodynamic consequences of theophylline intoxication with landiolol in halothane-anesthetized dogs. Can J Anesth 2000; 47: 265-72.
14. Sugiyama A, Takahara A, Hashimoto K. Electrophysiologic, cardiohemodynamic and β-blocking actions of a new ultra-short-acting β-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. J Cardiovasc Pharmacol 1999; 34: 70-7.
15. Shiroya T, Matsumori Y, Sawada S, et al. Effect of ONO-1101, an ultra-short acting β1-blocker, on cardiohemodynamics in anesthetized dogs (Japanese). Clin Res 1997; 31: 2949-65.
16. Carceles MD, Aleixandre F, Fuente T, Lopez-Vidal J, Laorden ML. Combined phosphodiesterase inhibition and β-blockade in the GI104313, decreases ischemia-induced arrhythmias in the rat. Can J Anesth 2001; 48: 486-92.
17. Zaugg M, Schaub MC, Pasch T, Spahn DR. Modulation of β-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action. Br J Anaesth 2002; 88: 101-23.